Foresite Capital Management IV’s OptiNose OPTN Stock Holding History

Foresite Capital Management IV’s Portfolio OPTN Stock Details OPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-58,051	Closed	-$8.03M	–	15
2019 Q4	$8.03M	Sell	58,051 -91,149	-61%	-$11.8M	3.46%	10
2019 Q3	$15.7M	Sell	149,200 -18,946	-11%	-$1.89M	5.06%	8
2019 Q2	$17.9M	Buy	168,146 +6,319	+4%	+$832K	5.05%	9
2019 Q1	$25M	Buy	161,827 +47,924	+42%	+$5.56M	8.99%	5
2018 Q4	$10.6M	Buy	113,903 +16,667	+17%	+$2.38M	4.86%	9
2018 Q3	$18.1M	Buy	97,236 +35,333	+57%	+$10.1M	5.94%	9
2018 Q2	$26M	Buy	61,903 +29,663	+92%	+$10M	8.86%	6
2018 Q1	$9.68M	Buy	32,240 +2,240	+7%	+$620K	4.01%	10
2017 Q4	$8.51M	Buy	+30,000	New	+$8.44M	5.96%	7

Other funds holding OPTN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Foresite Capital Management IV's OPTN Position: Q1 2020 in Review

Foresite Capital Management IV sold out of OptiNose (OPTN) in Q1 2020, closing a stake of 58,051 shares — an estimated $8.03M sold.

Foresite Capital Management IV first reported a position in OPTN in Q4 2017 and held it in 9 quarters. The position peaked at $26M in Q2 2018. 81 funds tracked by Wall St. Rank hold OPTN as of Q1 2020.

Foresite Capital Management IV reported no remaining OptiNose position as of Q1 2020 after selling out during the quarter.
Foresite Capital Management IV sold 58,051 OptiNose shares in Q1 2020, an estimated $8.03M.
Foresite Capital Management IV first reported a position in OptiNose in Q4 2017 and held it in 9 quarters.
Foresite Capital Management IV's OptiNose position peaked at $26M in Q2 2018.
81 funds tracked by Wall St. Rank held OptiNose as of Q1 2020.

Based on Foresite Capital Management IV's 13F filing for Q1 2020, filed 14 May 2020.